Therapeutic strategy of untreated de novo acute myeloid leukemia in the elderly: the efficacy of continuous drip infusion with low dose cytarabine and etoposide

Author： Tsurumi Hisashi   Kanemura Nobuhiro   Hara Takeshi   Kasahara Senji   Yamada Toshiki   Sawada Michio   Oyama Masami   Moriwaki Hisataka  

Publisher： Springer Publishing Company

ISSN： 0171-5216

Source： Journal of Cancer Research and Clinical Oncology, Vol.133, Iss.8, 2007-08, pp. : 547-553

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemia

By Klisovic Rebecca B.   Blum William   Liu Zhongfa   Xie Zhiliang   Kefauver Cheryl   Huynh Lenguyen   Zwiebel James A.   Devine Steven M.   Byrd John C.   Grever Michael R.   Chan Kenneth K.   Marcucci Guido  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1332-1336

Informa Healthcare

Access to resources Recommend Favorite

Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule

By Damon Lloyd   Johnston Laura   Ries Curt   Rugo Hope   Case Delvyn   Ault Kenneth   Linker Charles  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 6, 2004-06 ,pp. : 468-474

Springer Publishing Company

Access to resources Recommend Favorite

Successful management of acute myeloid leukemia transformed from chronic myelomonocytic leukemia in the elderly by a combination regimen of decitabine and cytarabine, aclarubicin and granulocyte colony-stimulating factor: A case report

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1217-1220

Spandidos Publications

Access to resources Recommend Favorite

Mixed lineage leukemiaseptin 5 fusion transcript in de novo adult acute myeloid leukemia with t(11;22)(q23;q11.2): A case report

By            

Oncology Letters, Vol. 7, Iss. 6, 2014-01 ,pp. : 1930-1932

Spandidos Publications

Access to resources Recommend Favorite

Efficacy of tosedostat, a novel, oral agent for elderly patients with relapsed or refractory acute myeloid leukemia: a review of the Phase II OPAL trial

By Mathisen Michael S   Ravandi Farhad  

Future Oncology, Vol. 8, Iss. 4, 2012-04 ,pp. : 351-357

Future Medicine

Access to resources Recommend Favorite